The Pennant Group, Inc. (PNTG)

Gold consolidates near recent highs within a bull pennant, poised for an upside breakout toward $5,345 while maintaining strong support above the 50-day moving average.

The Pennant Group, Inc. (PNTG) Q4 2025 Earnings Call Transcript

Although the revenue and EPS for The Pennant Group (PNTG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

EAGLE, Idaho, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.84 for the full year and $0.24 for the fourth quarter of 2025. Pennant also reported adjusted diluted earnings per share of $1.18 for the full year and $0.34 for the quarter(1 ).

The Pennant Group (PNTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EAGLE, Idaho, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its fourth quarter and fiscal year 2025 financial results on Wednesday, February 25, 2026. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, February 26, 2026, at 10:00 a.m.

Crude oil is consolidating in a bull pennant near key moving averages, with contracting volatility signaling a potential upside breakout that could extend the January bullish reversal.

Campbell and CO Investment Adviser LLC decreased its position in The Pennant Group, Inc. (NASDAQ: PNTG) by 46.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,672 shares of the company's stock after selling 20,710 shares during the period. Campbell and CO

The Pennant Group (NASDAQ: PNTG - Get Free Report) and Encompass Health (NYSE: EHC - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Earnings and Valuation This table compares The

An aging population and rising AI adoption position the Zacks Medical - Outpatient and Home Healthcare industry for solid growth. EHC, DVA, OPCH and PNTG stand to benefit.

The Pennant Group, Inc. (PNTG) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PNTG's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

Creative Planning increased its stake in The Pennant Group, Inc. (NASDAQ: PNTG) by 23.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,125 shares of the company's stock after purchasing an additional 5,364 shares during the period. Creative

Geode Capital Management LLC raised its holdings in The Pennant Group, Inc. (NASDAQ: PNTG) by 4.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 832,481 shares of the company's stock after purchasing an additional 36,357 shares during the

Gold formed a small bull pennant near the top of the current leg, reclaiming the 10-day average Tuesday while tagging the long-term upper channel line and a downtrend-line convergence just above $4,159.

The Pennant Group, Inc. (NASDAQ: PNTG - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month target price

The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.